March 30, 2026 | Pre- Congress Workshops

March 31 - April 2, 2026 | Main Congress Days

WALTER E. WASHINGTON CONVENTION CENTER, WASHINGTON D.C.

R&D + Strategic Partnering
for the Global Vaccine Industry

BOOK TICKET - 55% OFF

APPLY TO SPONSOR /EXHIBIT /SPEAK

WORLD’S LEADING VACCINE EVENT

4,000+

Attendees

550+

Speakers

300+

Exhibitors

100+

Start-ups

4

Days

12

Tracks

15

Workshops

2,500+

Partnering Meetings

The Most Important Vaccine Event of The Year

CONFERENCE

550+ SPEAKERS

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more

APPLY TO SPEAK

EXHIBITION

MEET YOUR MARKET

300+ leading solution providers from across the globe, featuring new ways of thinking and novel partnerships to generate solutions

EXHIBIT / SPONSOR NOW

NETWORKING

IN-PERSON

Networking is at the heart of World Vaccine Congress Washington. Our congress allows you to connect directly with thousands of vaccine experts across 4 days of built-in 1-2-1 networking

GET YOUR TICKETS

Early Bird Offer Save US$3,020

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

Clinical Trials
Understand how to move your vaccine candidates through development phases to licensure

Immune Profiling
Explores recent efforts into infectious disease modelling, immune characterization and T/B cell interplay.

Pandemic Platforms
The most promising platforms that can be used for an outbreak, from pathogen adaptability to speed, scale up and implementation

Cancer & Immunotherapy
Cancer vaccines and the future of combination treatments

Supply & Logistics
Learn how we are dealing with the supply demands and the technologies that will allow last mile delivery

Vaccine Access
Understand the dynamics governing global vaccine markets & what interventions can be made for better access

Influenza & Respiratory
Latest updates in RSV, influenza, pneumococcal, pan- and combinational vaccines

Vaccine Safety
New tools to measure vaccine surveillance, safety and managing misinformation

Veterinary
A one health approach to battle emerging zoonotic diseases and climate change

Bioprocessing & Manufacturing
Meet with the manufacturers & bioprocessing experts to advance your vaccine formulation, tech transfer & scale-up

Partnerships
Secure funding and navigate through successful Public-Private-Partnerships with all stakeholders

Emerging & Re-Emerging Diseases
From Disease X preparedness, neglected diseases to global health vaccine development & new platforms

GET YOUR TICKETS

APPLY TO SPEAK

EARLY CONFIRMED 2026 SPEAKERS

David Burkhart
CEO
Inimmune Corp

Holger Kissel
Senior Vice President
BioNTech

Charles Kline
Associate Vice President
Merck
Arvind Kumar
Vice President of Research
BiomEdit

Francesca Micoli
Director GVGH Innovation Academy and Senior Project Leader
GVGH

Mayur Patel
VP Global R&D Product Development and Portfolio Management
Elanco
Lora Shimp
Director - Immunization Center
John Snow Inc

Christian Harding
CSO & Co-founder
Omniose

Brian Abramson
Board of Directors
National Vaccine Law Association
Navneet Bichha
Senior Program Officer
The INCLEN Trust International

Tom Mahoney
Senior Advisor, EdJen Biotech LLC; Investor & Advisor
Harvard T.H. Chan School of Public Health

Victoria Standley
Immunization Program Specialist
Sanford Health
Michael Good
Head, Laboratory of Vaccines for the Developing World, and NHMRC Investigator Fellow
Institute for Biomedicine and Glycomics, Griffith University

Raiees Andrabi
Associate Professor of Medicine
University of Pennsylvania

Julia Barnes-Weise
Executive Director
GHIAA
Tonya Colpitts
AVP, Global Project Head, Vaccines
Sanofi

John El-Attrache
Director of Scientific Services
CEVA santé Animale

Caroline Heller
Chief Business Officer
Rumin8
Hitesh Hurkchand
Senior Consultant
Gates Foundation

Alasdair King
Executive Director
Merck Animal Health

Kayvon Modjarrad
Executive Director, Viral Vaccines
Pfizer
Montrece Ransom
Director
The National Coordinating Center for Public Health Training

Joanie Robertson
Program Advisor
PATH

Sushant Sahastrabuddhe
Deputy Director General
International Vaccine Institute
Lindsey Shields
Deputy Director, Epidemic Prepardness and Response
PATH

Daniel Wolfe
Deputy Direct, BARDA CBRN Medical Countermeasures
Biomedical Advanced Research And Development Authority

Raymond Goodrich
Professor
Colorado State University
Glenn Rockman
Founder And Managing Partner
Adjuvant Capital

Petro Terblanche
Chief Executive Officer
Afrigen Biologics (Pty) Ltd

Seth Berkley
Senior Advisor,
Pandemic Center at Brown Univertsity
Maria Elena Bottazzi
Co-Director of Texas Children's Hospital Center for Vaccine Development
Baylor College of Medicine

Susan Dentzer
President & CEO
America's Physician Groups

Vega Masignani
Alliance Director
CARB-X
Usman Nakakana
Senior Program officer vaccine development and impact
Gates Foundation

Reda Rawi
Head Structural Bioinformatics Core
Vaccine Research Center, NIAID, NIH

Nikki Romanik
Distinguished Senior Fellow
Brown University School of Public Health
Rajinder Suri
Chief Executive Officer
Developing Countries Vaccine Manufacturers Network

James Wassil
COO
Vaxcyte

Maria Karasarides
Former Vice President, Worldwide Medical Oncology, Early Assets & Biomarkers
The Delphina Group
Haritha Adhikarla
Senior Translational Immunology Lead
CEPI

Galit Alter
Professor Of Medicine
Ragon Institute of MGH, MIT and Harvard

Pascal Barollier
Chief Engagement and Information Officer
Gavi, the vaccine Alliance
Robert Chen
Scientific Director
BRIGHTON Collaboration

Dennis Christensen
Head of Global R&D
Croda

Kashmira Date
Senior Director, Medical & Scientific Affairs (Pipeline Vaccines)
Pfizer
Stephen Framil
Corporate Global Head of Accessibility
Merck & Co. Inc.

Cyril Gay
Science Advisor, Countermeasures Discovery, Development, and Strategic Public-Private Partnerships
USDA

Andrew Geall
Chief Development Officer
Replicate Bioscience, Inc.
Bruce Gellin
Professor of Medicine
Georgetown University School Of Medicine

Bill Hausdorff
Lead, Meningococcal Vaccine Development and Vaccines Public Health Value Proposition and
PATH, Center for Vaccine Innovation and Access

Peter Hotez
Professor
Baylor College of Medicine
David Humphreys
Executive Advisor
Triangulate health Ltd

Jerome Kim
Director General
ivi

Mahesh Kumar
Senior VP, Global Biologics R&D
Zoetis
Ofer Levy
Director, Precision Vaccines Program
Boston Children's Hospital

Sania Nishtar
Chief Executive Officer
Gavi, the vaccine Alliance

Gregory Poland
Director of Mayo Vaccine Research Group
Mayo Clinic
Angela Shen
Consultant
University of Pennsylvania

Walter Straus
Vice President, Clinical Safety & Risk Management
Moderna Therapeutics

Vic Suarez
Principal Growth Partner
Blu Zone Bioscience
Valeria Szijarto
Director of Bacterial Vaccine Discovery
AstraZeneca

Prashant Yadav
Senior Fellow
Council on Foreign Relations

Max Bayer
Pharma Reporter
Endpoints News
Geetha Srinvas
Director, CVB
USDA

Ken Cohen
Executive Director of Translational Research,
Southwest Medical Associates

Stephen Parodi
EVP, External Affairs and Corporate Development and Associate Executive Director, T
The Permanente Medical Group Inc
Sandeep Patel
CEO
Humanity Health Ventures

GET YOUR TICKETS

SEE SPEAKER LIST

SPONSOR OR EXHIBIT

Remaining marketing opportunities for world class solution providers are selling fast.
Contact: Michael.Hodge@terrapinn.com

GET THE SPONSORSHIP
& EXHIBITION BROCHURE

“Very well presented conference, excellent speakers and I gained a lot of insight and knowledge. Excellent networking opportunities with new and existing contacts.”

- Genesis Research Services

“The event brought together some of the most innovative and driven professionals in the industry, creating an inspiring space for collaboration, scientific exchange, and meaningful connections.”

- Omnicure Clinical Research

“The meetings were outstanding. This is the best meeting of the year for us. The start-up zone is amazing. The talks are timely and on-point and it is a great networking meeting.”

- Microbiologics Inc.

“This is an incredibly valuable conference for learning about the state of the vaccine industry.“

- Merck

“Hard to imagine how anyone could do more brilliantly. This year’s meeting was especially meaningful.”

- Peter Hotez, Professor, Baylor College of Medicine

R&D + Strategic Partnering
for the Global Vaccine Industry

WORLD’S LEADING VACCINE EVENT

4,000+

550+

300+

100+

4

12

15

2,500+

The Most Important Vaccine Event of The Year

Early Bird Offer Save US$3,020

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

EARLY CONFIRMED 2026 SPEAKERS

2026 Early Confirmed Sponsors and Exhibitors

Created by

R&D + Strategic Partnering for the Global Vaccine Industry

WORLD’S LEADING VACCINE EVENT

4,000+

550+

300+

100+

4

12

15

2,500+

The Most Important Vaccine Event of The Year

Early Bird Offer Save US$3,020

The Start-to-Finish of Vaccines

From research, immune profiling & clinical trials to manufacture and access

EARLY CONFIRMED 2026 SPEAKERS

2026 Early Confirmed Sponsors and Exhibitors

Created by

R&D + Strategic Partnering
for the Global Vaccine Industry